​

Scinai Immunotherapeutics Ownership | Who Owns Scinai Immunotherapeutics?

OverviewChartTranscripts

Scinai Immunotherapeutics Ownership Summary

Scinai Immunotherapeutics is owned by 8.09% institutional investors, 18.22% insiders, and 73.69% retail investors.

SCNI Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockScinai Immunotherapeutics8.09%18.22%73.69%
SectorHealthcare Stocks 279.17%10.51%-189.68%
IndustryBiotech Stocks 63.95%10.67%25.38%

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2024129.09%409,939-11.35%85.78%5-2-
Dec 31, 20231122.22%462,433-24.72%116.91%5-16.67%2-
Sep 30, 20239-18.18%614,306179.14%1330.88%6200.00%--100.00%
Jun 30, 20231110.00%220,069-43.33%64.53%2-50.00%4300.00%
Mar 31, 202310-388,32160.43%117.27%4-60.00%1-

Recent Insider Transactions

DateNameRoleActivityValue
Sep 28, 2005BARRON PARTNERS LP-Sell$251.77K
Sep 26, 2005BARRON PARTNERS LP-Sell$2.50K
Sep 23, 2005BARRON PARTNERS LP-Sell$2.55K

SCNI Ownership FAQ

Who Owns Scinai Immunotherapeutics?

Scinai Immunotherapeutics shareholders are primarily institutional investors at 8.09%, followed by 18.22% insiders and 73.69% retail investors. The average institutional ownership in Scinai Immunotherapeutics's industry, Biotech Stocks , is 63.95%, which Scinai Immunotherapeutics falls below.

Does Blackrock own Scinai Immunotherapeutics?

BlackRock is not among the top 10 institutional shareholders of Scinai Immunotherapeutics.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools